Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta‐analysis
Background Polypharmacy (PP) and potentially inappropriate medications (PIM) are highly
prevalent in older adults with cancer. This study systematically reviews the associations of …
prevalent in older adults with cancer. This study systematically reviews the associations of …
Systematic review and meta-analysis on the associations of polypharmacy and potentially inappropriate medication with adverse outcomes in older cancer patients
LJ Chen, K Trares, DC Laetsch… - The Journals of …, 2021 - academic.oup.com
Background Both polypharmacy and potentially inappropriate medication (PIM) intake are
highly prevailing in older cancer patients. However, only studies on the association of …
highly prevailing in older cancer patients. However, only studies on the association of …
Association of polypharmacy and potentially inappropriate medications with physical functional impairments in older adults with cancer
Background: Polypharmacy and potentially inappropriate medications (PIMs) are prevalent
in older adults with cancer, but their associations with physical function are not often studied …
in older adults with cancer, but their associations with physical function are not often studied …
Association of polypharmacy and potentially inappropriate medications with frailty among older adults with blood cancers
TT Hshieh, C DuMontier, T Jaung, NE Bahl… - Journal of the National …, 2022 - jnccn.org
Background: Polypharmacy and potentially inappropriate medications (PIMs) are common
among older adults with blood cancers, but their association with frailty and how to manage …
among older adults with blood cancers, but their association with frailty and how to manage …
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults
Multifactorial geriatric syndromes are highly prevalent in older patients with cancer. Because
an increasing number of older patients undergo allogeneic hematopoietic stem cell …
an increasing number of older patients undergo allogeneic hematopoietic stem cell …
Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: A cross-sectional study
S Kim, S Park, SH Yoo, KH Choi, JY Lee - Journal of Geriatric Oncology, 2023 - Elsevier
Introduction We aimed to estimate the nationwide prevalence of potentially inappropriate
medication (PIM) use in patients with terminal cancer according to two deprescribing criteria …
medication (PIM) use in patients with terminal cancer according to two deprescribing criteria …
Multidisciplinary care in the hematology clinic: implementation of geriatric oncology
V Goede, R Stauder - Journal of geriatric oncology, 2019 - Elsevier
Multidisciplinary care is believed to provide benefits to patients with cancer. Tumor board
conferences as well aspalliative care or psycho-oncological services have not only become …
conferences as well aspalliative care or psycho-oncological services have not only become …
[HTML][HTML] Impact of polypharmacy prior to allogeneic hematopoietic stem cell transplantation in older adults
M Sugidono, M Lo, R Young, K Rosario, Y Jung… - … and Cellular Therapy, 2021 - Elsevier
Polypharmacy is common in older adults with cancer, but there is little evidence evaluating
the impact of polypharmacy and other medication hazards on allogeneic hematopoietic cell …
the impact of polypharmacy and other medication hazards on allogeneic hematopoietic cell …
The influence of polypharmacy, potentially inappropriate medications, and drug interactions on treatment completion and prognosis in older patients with ovarian …
TL Jørgensen, J Herrstedt - Journal of geriatric oncology, 2020 - Elsevier
Background Older patients with cancer are at increased risk of exposure to polypharmacy
(PP), potential drug interactions (PDIs), and Potentially inappropriate Medications (PIMs) …
(PP), potential drug interactions (PDIs), and Potentially inappropriate Medications (PIMs) …
[HTML][HTML] Use of potentially inappropriate medications in older allogeneic hematopoietic cell transplantation recipients
D Bhargava, M Arora, TE DeFor, CG Brunstein… - Biology of Blood and …, 2020 - Elsevier
The use of potentially inappropriate medications (PIMs) using Beers criteria and its impact
on older allogeneic hematopoietic cell transplantation (HCT) recipients is not known. Here …
on older allogeneic hematopoietic cell transplantation (HCT) recipients is not known. Here …